LINDSEY MAAS: Open Payments
NPI 1669027421 · SCOTTSBLUFF, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 27 payments from 9 companies in 2025. Trend: 2023 $49 · 2024 $645 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $138 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $127 |
| ABBVIE INC. | 4 | $86 |
| Biogen, Inc. | 3 | $67 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| CooperSurgical, Inc. | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Organon LLC | 1 | $11 |
Products named: Veozah, ZURZUVAE, MYFEMBREE, LILETTA, Paragard T 380A, QULIPTA, OMNI HYSTEROSCOPE, LO LOESTRIN FE.
Industry payments across NE — which companies pay providers there.
